Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 14/20 | 0.51 |
| ▸ | ABCB1 | P08183 | 8/20 | 0.51 |
| ▸ | ABCC1 | P33527 | 3/20 | 0.46 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.46 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.45 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.45 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.45 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.45 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.45 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.45 |
| ▸ | MYC | P01106 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31643041 | 0.93 | ABCG2 (0.49) | ABCG2ABCB1ABCC1ALDH1A3GABRA1 | |
| SCHEMBL27453359 | 0.93 | ABCG2 (0.49) | ABCG2ABCB1ABCC1ALDH1A3GABRA1 | |
| SCHEMBL25875705 | 0.93 | ABCG2 (0.46) | ABCG2ABCB1ABCC1ALDH1A3GABRA1 | |
| SCHEMBL27368624 | 0.93 | ABCG2 (0.49) | ABCG2ABCB1ABCC1ALDH1A3GABRA1 | |
| SCHEMBL26592150 | 0.93 | ABCG2 (0.46) | ABCG2ABCB1ABCC1ALDH1A3GABRA1 | |
| SCHEMBL27453612 | 0.93 | ABCG2 (0.49) | ABCG2ABCB1ABCC1ALDH1A3GABRA1 | |
| SCHEMBL31642779 | 0.92 | ABCG2 (0.51) | ABCG2ABCB1ABCC1GABRA1GABRG2 | |
| SCHEMBL31643499 | 0.91 | ABCG2 (0.48) | ABCG2ABCB1ABCC1ALDH1A3GABRA1 | |
| SCHEMBL25875320 | 0.91 | ABCG2 (0.47) | ABCG2ABCB1ABCC1ALDH1A3GABRA1 | |
| SCHEMBL27368625 | 0.91 | ABCG2 (0.50) | ABCG2ABCB1ABCC1GABRA1GABRG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11737357-B2 | Compound and organic light-emitting device comprising same | LG CHEM, LTD. | 2023-08-22 | — | — | US | disclosed |
| US-11737357-B2 | Compound and organic light-emitting device comprising same | LG CHEM, LTD. | 2023-08-22 | — | — | US | disclosed |
| US-20230255104-A1 | Compound And Organic Light-Emitting Device Comprising Same | LG CHEM, LTD. (KR) | 2023-08-10 | — | — | US | disclosed |
| US-20230255104-A1 | Compound And Organic Light-Emitting Device Comprising Same | LG CHEM, LTD. (KR) | 2023-08-10 | — | — | US | disclosed |
| EP-3351537-B1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEMICAL LTD (KR) | 2023-01-18 | — | — | EP | disclosed |
| EP-3351536-B1 | ORGANIC LIGHT-EMITTING DEVICE | LG CHEMICAL LTD (KR) | 2021-07-21 | — | — | EP | disclosed |
| US-10367149-B2 | Organic light-emitting device | LG CHEM, LTD. (KR) | 2019-07-30 | — | — | US | disclosed |
| US-20190055222-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2019-02-21 | — | — | US | disclosed |
| EP-3351536-A1 | ORGANIC LIGHT-EMITTING DEVICE | LG Chem, Ltd. (KR) | 2018-07-25 | — | — | EP | disclosed |
| EP-3351537-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG Chem, Ltd. (KR) | 2018-07-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11737357-B2 | Compound and organic light-emitting device comprising same | CRY1, CYP1B1, CYP1A1 | ABCG2 939/4885ABCB1 206/4885ABCC1 449/4885 |
| US-20230255104-A1 | Compound And Organic Light-Emitting Device Comprising Same | ARL1, AR, ALG3 | ABCG2 2609/4885ABCB1 2021/4885ABCC1 1796/4885 |
| US-10367149-B2 | Organic light-emitting device | CRY1, PPOX, CRY2 | ABCG2 3141/4885ABCB1 2481/4885ABCC1 3713/4885 |
| US-20190055222-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CRY1, CYP1B1, CYP1A1 | ABCG2 939/4885ABCB1 206/4885ABCC1 449/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.